As such they gain licences for adjunctive therapy in patients with uncontrolled focal epilepsies from short placebo controlled trials determining the ‘responder rate’ for a seizure reduction of 50% or more.
As such they gain licences for adjunctive therapy in patients with uncontrolled focal epilepsies from short placebo controlledtrials determining the ‘responder rate’ for a seizure reduction of 50% or more.